The FDA and Centers for Disease Control and Prevention announced Tuesday that they are recommending that the use of the single-dose Johnson & Johnson vaccine be halted after six cases of a rare and severe type of blood clot were reported in the United States.
The dangerous clots developed about two weeks after the vaccine was administered in these patients—all of them women between the ages of 18 and 48, according to ABC News.
Read More